BTIG Upgrades Tracon Pharmaceuticals (TCON) to Buy
Tweet Send to a Friend
BTIG analyst Robert Hazlett upgraded Tracon Pharmaceuticals (NASDAQ: TCON) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
